HDFC Pharma and Healthcare Fund vs SBI Long Term Advantage Fund - Series III
Portfolio Overlap Analysis · HDFC vs SBI
5.4%
Low Overlap
1 common stocks · Rank #27542 of 28,292 pairs
Common Holdings (1)
| Stock | Wt% in HDFC Pharma and Healthcare | Wt% in SBI Long Term Advantage Fund - | Overlap |
|---|---|---|---|
Aster DM Healthcare Ltd. Healthcare Services | 5.46% | 5.42% | 5.42% |
Unique to HDFC Pharma and Healthcare
- Sun Pharmaceutical Industries Ltd.9.81%
- Divis Laboratories Ltd.8.38%
- Glenmark Pharmaceuticals Ltd.6.62%
- Lupin Ltd.6.44%
- Max Healthcare Institute Limited6.36%
- Alkem Laboratories Ltd.6.21%
- Ipca Laboratories Ltd.4.80%
- Anthem Biosciences Limited4.46%
- Fortis Healthcare Limited4.02%
Unique to SBI Long Term Advantage Fund -
- Reliance Industries Ltd.8.10%
- HDFC Bank Ltd.5.92%
- Axis Bank Ltd.5.66%
- Larsen & Toubro Ltd.5.19%
- State Bank of India5.10%
- ICICI Bank Ltd.4.95%
- Kotak Mahindra Bank Ltd.3.62%
- Bank of Baroda3.41%
- Bajaj Finserv Ltd.3.17%
Sector Overlap Breakdown
Healthcare Services5.4% (1)
Analysis
AI-generated comparative analysis coming soon.
More comparisons for HDFC Pharma and Healthcare
- vs SBI Healthcare Opportunities54.8% · 16 stocks
- vs HEALETF46.5% · 10 stocks
- vs NH42.6% · 10 stocks
- vs NIPPON INDIA PHARMA41.7% · 13 stocks
- vs ICICI Prudential Nifty Pharma 40.0% · 9 stocks
More comparisons for SBI Long Term Advantage Fund -
- vs HDFC BSE Sensex Index38.6% · 9 stocks
- vs Nippon India Index Fund - BSE 38.6% · 9 stocks
- vs Nippon India ETF BSE Sensex38.6% · 9 stocks
- vs SBI BSE Sensex ETF38.6% · 9 stocks
- vs SBI BSE Sensex Index38.6% · 9 stocks
Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.